| Ms Ysabelle Stuard, APRN | |
|
15 Carrington Rd, Bethany, CT 06524-3531 | |
| (303) 818-0355 | |
| Not Available |
| Full Name | Ms Ysabelle Stuard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 15 Carrington Rd, Bethany, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902574379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 12.009933 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Urgent Care Centers Llc | 7618242777 | 134 |
News Archive
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
A new Brandeis University study of twins shows that genes play a significant role in the level of hearing loss that often appears in late middle age. The research, in the Journal of Gerontology Medical Sciences, examined genetic and environmental factors affecting hearing loss in the frequency range of speech recognition.
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
The U.S. Food and Drug Administration (FDA) today issued the "Critical Path Opportunities for Generic Drugs" report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.
The American Physical Therapy Association (APTA) cites the results of the first study to show the effectiveness of early physical therapy for patients in a medical intensive care unit (ICU).
› Verified 5 days ago
| Entity Name | Hartford Healthcare Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093239683 PECOS PAC ID: 7618242777 Enrollment ID: O20170929001464 |
News Archive
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
A new Brandeis University study of twins shows that genes play a significant role in the level of hearing loss that often appears in late middle age. The research, in the Journal of Gerontology Medical Sciences, examined genetic and environmental factors affecting hearing loss in the frequency range of speech recognition.
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
The U.S. Food and Drug Administration (FDA) today issued the "Critical Path Opportunities for Generic Drugs" report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.
The American Physical Therapy Association (APTA) cites the results of the first study to show the effectiveness of early physical therapy for patients in a medical intensive care unit (ICU).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Ysabelle Stuard, APRN 15 Carrington Rd, Bethany, CT 06524-3531 Ph: (303) 818-0355 | Ms Ysabelle Stuard, APRN 15 Carrington Rd, Bethany, CT 06524-3531 Ph: (303) 818-0355 |
News Archive
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
A new Brandeis University study of twins shows that genes play a significant role in the level of hearing loss that often appears in late middle age. The research, in the Journal of Gerontology Medical Sciences, examined genetic and environmental factors affecting hearing loss in the frequency range of speech recognition.
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
The U.S. Food and Drug Administration (FDA) today issued the "Critical Path Opportunities for Generic Drugs" report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.
The American Physical Therapy Association (APTA) cites the results of the first study to show the effectiveness of early physical therapy for patients in a medical intensive care unit (ICU).
› Verified 5 days ago
Tatiana A. Goclowski, MSN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 187 Beacon Rd, Bethany, CT 06524 Phone: 413-388-2892 |